Cell-mediated immune responses induced by BHV-1: rational vaccine design

References

• Engels M, Ackermann M. Pathogenesis of ruminant herpesvirus infections. Vet. Microbiol.53, 3–15 (1996).
   PubMed Web of Science ®Google Scholar
• Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev.16, 79–95 (2003).
   PubMed Web of Science ®Google Scholar
• Ackermann M, Engels M. Pro and contra IBR-eradication. Vet. Microbiol.113, 293–302 (2006).
   PubMed Web of Science ®Google Scholar
• Schwyzer M, Ackermann M. Molecular virology of ruminant herpesviruses. Vet. Microbiol.53, 17–29 (1996).
   PubMed Web of Science ®Google Scholar
• Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature421, 852–856 (2003).
   PubMed Web of Science ®Google Scholar
• Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science300, 337–339 (2003).
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Babiuk LA. Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1. J. Clin. Microbiol.23, 274–282 (1986).
   PubMed Web of Science ®Google Scholar
• Marshall RL, Israel BA, Letchworth GJ 3rd. Monoclonal antibody analysis of bovine herpesvirus-1 glycoprotein antigenic areas relevant to natural infection. Virology165, 338–347 (1988).
   PubMed Web of Science ®Google Scholar
• Leary TP, Splitter GA. Recombinant herpesviral proteins produced by cell-free translation provide a novel approach for the mapping of T lymphocyte epitopes. J. Immunol.145, 718–723 (1990).
   PubMed Web of Science ®Google Scholar
• Tikoo SK, Campos M, Popowych YI, van Drunen Littel-van den Hurk S, Babiuk LA. Lymphocyte proliferative responses to recombinant bovine herpes virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. Viral Immunol.8, 19–25 (1995).
   PubMed Web of Science ®Google Scholar
• Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M, Srikumaran S. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine20, 3744–3751 (2002).
   PubMed Web of Science ®Google Scholar
• Huang Y, Babiuk LA, van Drunen Littel- van den Hurk S. Immunization with a bovine herpesvirus-1 glycoprotein B DNA vaccine induces cytotoxic T lymphocyte responses in mice and cattle. J. Gen. Virol.88, 887–898 (2005).
   Google Scholar
• Denis M, Slaoui M, Keil G et al. Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology78, 7–13 (1993).
   PubMed Web of Science ®Google Scholar
• Hopkins JI, Fiander AN, Evans AS, Delchambre M, Gheysen D, Borysiewicz LK. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J. Med. Virol.49, 124–131 (1996).
   PubMed Web of Science ®Google Scholar
• Tigges MA, Koelle D, Hartog K, Sekulovich RE, Corey L, Burke RL. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol.66, 1622–1634 (1992).
   PubMed Web of Science ®Google Scholar
• Yasukawa M, Zarling JM. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses. J. Immunol.134, 2679–2682 (1985).
   PubMed Web of Science ®Google Scholar
• Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol.166, 4049–4058 (2001).
   PubMed Web of Science ®Google Scholar
• Mikloska Z, Ruckholdt M, Ghadiminejad I, Dunckley H, Denis M, Cunningham AL. Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-γ and IL-12 production. J. Immunol.164, 5167–5176 (2000).
   PubMed Web of Science ®Google Scholar
• Breinig F, Heintel T, Schumacher A, Meyerhans A, Schmitt MJ. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast. FEMS Immunol. Med. Microbiol.38, 231–239 (2003).
   PubMed Web of Science ®Google Scholar
• Sadzot-Delvaux C, Rentier B. The role of varicella zoster virus immediate-early proteins in latency and their potential use as components of vaccines. Arch. Virol. Suppl.17, 81–89 (2001).
   Google Scholar
• Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral Immunol.4, 151–166 (1991).
   PubMedGoogle Scholar
• Hanon E, Keil G, van Drunen Littel-van den Hurk S et al. Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D. Virology257, 191–197 (1999).
   PubMed Web of Science ®Google Scholar
• Winkler MT, Doster A, Jones C. Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. J. Virol.73, 8657–8668 (1999).
   PubMed Web of Science ®Google Scholar
• Devireddy LR, Jones CJ. Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. J. Virol.73, 3778–3788 (1999).
   PubMed Web of Science ®Google Scholar
• Gopinath RS, Ambagala AP, Hinkley S, Srikumaran S. Effects of virion host shut-off activity of bovine herpesvirus 1 on MHC class I expression. Viral Immunol.15, 595–608 (2002).
   PubMed Web of Science ®Google Scholar
• Koppers-Lalic D, Rijsewijk FA, Verschuren SB et al. The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1. J. Gen. Virol.82, 2071–2081 (2001).
   PubMed Web of Science ®Google Scholar
• Koppers-Lalic D, Rychlowski M, van Leeuwen D et al. Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. Arch. Virol.148, 2023–2037 (2003).
   PubMed Web of Science ®Google Scholar
• Koppers-Lalic D, Reits EA, Ressing ME et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl Acad. Sci. USA102, 5144–5149 (2005).
   PubMed Web of Science ®Google Scholar
• Bryant NA, Davis-Poynter N, Vanderplasschen A, Alcami A. Glycoprotein G isoforms from some αherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J.22, 833–846 (2003).
   PubMed Web of Science ®Google Scholar
• Salerno-Goncalves R, Sztein MB. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol.14, 536–542 (2006).
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell124, 849–863 (2006).
   PubMed Web of Science ®Google Scholar
• Kaech SM, Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol.2, 415–422 (2001).
   PubMed Web of Science ®Google Scholar
• Hayday A, Tigelaar R. Immunoregulation in the tissues by γδ T cells. Nat. Rev. Immunol.3, 233–242 (2003).
   PubMed Web of Science ®Google Scholar
• Hayday AC. [γ][δ] cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol.18, 975–1026 (2000).
   PubMed Web of Science ®Google Scholar
• Chen ZW, Letvin NL. Adaptive immune response of Vγ2Vδ2 T cells: a new paradigm. Trends Immunol.24, 213–219 (2003).
   PubMed Web of Science ®Google Scholar
• Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and γδ T lymphocytes. Infect. Immun.69, 7550–7558 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson HL, Amara RR. T cell vaccines for microbial infections. Nat. Med.11, S25–S32 (2005).
   PubMed Web of Science ®Google Scholar
• Platt R, Burdett W, Roth JA. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine. Am. J. Vet. Res.67, 1179–1184 (2006).
   PubMed Web of Science ®Google Scholar
• Hein WR, Mackay CR. Prominence of γ δ T cells in the ruminant immune system. Immunol. Today12, 30–34 (1991).
   PubMedGoogle Scholar
• Braun RP, Babiuk LA, Loehr BI, van Drunen Littel-van den Hurk S. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology265, 46–56 (1999).
   PubMed Web of Science ®Google Scholar
• Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol.76, 9002–9010 (2002).
   PubMed Web of Science ®Google Scholar
• Loehr BI, Willson P, Babiuk LA, van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J. Virol.74, 6077–6086 (2000).
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Braun RP, Lewis PJ et al. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol.79, 831–839 (1998).
   PubMed Web of Science ®Google Scholar
• Quade MJ, Roth JA. Antigen-specific in vitro activation of T-lymphocyte subsets of cattle immunized with a modified live bovine herpesvirus 1 vaccine. Viral Immunol.12, 9–21 (1999).
   PubMed Web of Science ®Google Scholar
• Platt R, Roth JA, Royer RL, Thoen CO. Monitoring responses by use of five-color flow cytometry in subsets of peripheral T cells obtained from cattle inoculated with a killed Mycobacterium avium subsp paratuberculosis vaccine. Am. J. Vet. Res.67, 2050–2058 (2006).
   PubMed Web of Science ®Google Scholar
• Patel JR. Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines. Vaccine23, 4054–4061 (2005).
   PubMed Web of Science ®Google Scholar
• Endsley JJ, Quade MJ, Terhaar B, Roth JA. BHV-1-specific CD4+, CD8+, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. Viral Immunol.15, 385–393 (2002).
   PubMed Web of Science ®Google Scholar
• Woolums AR, Siger L, Johnson S, Gallo G, Conlon J. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon γ production. Vaccine21, 1158–1164 (2003).
   PubMed Web of Science ®Google Scholar
• Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med.184, 1555–1560 (1996).
   PubMed Web of Science ®Google Scholar
• Corr M, von Damm A, Lee DJ, Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol.163, 4721–4727 (1999).
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet. Microbiol.113, 275–282 (2006).
   PubMed Web of Science ®Google Scholar
• van Oirschot JT. Diva vaccines that reduce virus transmission. J. Biotechnol.73, 195–205 (1999).
   PubMed Web of Science ®Google Scholar
• Kaashoek MJ, Moerman A, Madic J et al. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine13, 342–346 (1995).
   PubMed Web of Science ®Google Scholar
• Kaashoek MJ, Rijsewijk FA, Ruuls RC et al. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine16, 802–809 (1998).
   PubMed Web of Science ®Google Scholar
• Mars MH, de Jong MC, van Oirschot JT. A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations. Vaccine18, 2120–2124 (2000).
   PubMed Web of Science ®Google Scholar
• Mars MH, de Jong MC, van Oirschot JT. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments. Vaccine18, 1975–1981 (2000).
   PubMed Web of Science ®Google Scholar
• Lemaire M, Meyer G, Baranowski E et al. Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves. J. Clin. Microbiol.38, 4233–4238 (2000).
   PubMed Web of Science ®Google Scholar
• Lemaire M, Weynants V, Godfroid J et al. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency. J. Clin. Microbiol.38, 1885–1894 (2000).
   PubMed Web of Science ®Google Scholar
• Rijsewijk FA, Kaashoek MJ, Langeveld JP et al. Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains. Arch. Virol.145, 921–936 (2000).
   PubMed Web of Science ®Google Scholar
• Makoschey B, Keil GM. Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis. Vet. Rec.147, 189–191 (2000).
   PubMed Web of Science ®Google Scholar
• Lemaire M, Schynts F, Meyer G et al. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. Vaccine19, 4795–4804 (2001).
   PubMed Web of Science ®Google Scholar
• Konig P, Beer M, Makoschey B et al. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain. Vaccine22, 202–212 (2003).
   PubMed Web of Science ®Google Scholar
• Zakhartchouk AN, Pyne C, Mutwiri GK et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J. Gen. Virol.80, 1263–1269 (1999).
   PubMed Web of Science ®Google Scholar
• Reddy PS, Idamakanti N, Pyne C et al. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. Vet. Immunol. Immunopathol.76, 257–268 (2000).
   PubMed Web of Science ®Google Scholar
• Gogev S, de Fays K, Versali MF, Gautier S, Thiry E. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine22, 1946–1953 (2004).
   PubMed Web of Science ®Google Scholar
• Gogev S, Vanderheijden N, Lemaire M et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine20, 1451–1465 (2002).
   PubMed Web of Science ®Google Scholar
• Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol.67, 5664–5667 (1993).
   PubMed Web of Science ®Google Scholar
• Lewis PJ, van Drunen Littel-van den Hurk S, Babiuk LA. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol.73, 10214–10223 (1999).
   PubMed Web of Science ®Google Scholar
• Braun RP, Babuik LA, van Drunen Littel-van den Hurk S. Enhanced immune responses to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vaccine Research6, 151–164 (1997).
   Google Scholar
• van Drunen Littel-van den Hurk S, Braun RP, Karvonen BC, King T, Yoo D, Babiuk LA. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. Virology260, 35–46 (1999).
   PubMed Web of Science ®Google Scholar
• Caselli E, Boni M, Di Luca D, Salvatori D, Cassai E. A combined bovine herpesvirus 1 gB-gD DNA vacccine induces immune responses in mice. Comp. Immunol. Microbiol. Infect. Dis.28, 155–166 (2005).
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Braun RP, Lewis PJ, Karvonen BC, Babiuk LA, Griebel PJ. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol.12, 67–77 (1999).
   PubMed Web of Science ®Google Scholar
• Oliveira SC, Harms JS, Rosinha GM, Rodarte RS, Rech EL, Splitter GA. Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host. J. Immunol. Methods245, 109–118 (2000).
   PubMed Web of Science ®Google Scholar
• Gupta PK, Saini M, Gupta LK et al. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet. Microbiol.78, 293–305 (2001).
   PubMed Web of Science ®Google Scholar
• Toussaint JF, Coen L, Letellier C et al. Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8. Vet. Res.36, 529–544 (2005).
   PubMed Web of Science ®Google Scholar
• Loehr BI, Rankin R, Pontarollo R et al. Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle. Virology289, 327–333 (2001).
   PubMed Web of Science ®Google Scholar
• Gerdts V, Babiuk LA, van Drunen Littel-van den Hurk S, Griebel PJ. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat. Med.6, 929–932 (2000).
   PubMed Web of Science ®Google Scholar
• Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J. Immunol.168, 1877–1885 (2002).
   PubMed Web of Science ®Google Scholar
• Pontarollo RA, Babiuk LA, Hecker R, van Drunen Littel-van den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J. Gen. Virol.83, 2973–2981 (2002).
   PubMed Web of Science ®Google Scholar
• Loehr BI, Pontarollo R, Rankin R et al. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. J. Gen. Virol.82, 3035–3043 (2001).
   PubMed Web of Science ®Google Scholar
• Tsang C, Babiuk S, van Drunen Littel- van den Hurk S, Babiuk LA, Griebel P. A single DNA immunization in combination with electroporation prolongs the primary immune response and the duration of immune memory. Vaccine DOI:10.1016/j.vaccine.2007.03.009 (2007) (Epub ahead of print).
   Google Scholar
• Toussaint JF, Dubois A, Dispas M, Paquet D, Letellier C, Kerkhofs P. Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle. Vaccine25(7), 1167–1174 (2006).
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J et al. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine12, 1295–1302 (1994).
   PubMed Web of Science ®Google Scholar
• Van Donkersgoed J, McCartney D, van Drunen Littel-van den Hurk S. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol. Can. J. Vet. Res.60, 55–58 (1996).
   PubMed Web of Science ®Google Scholar
• Krieg A. Therapeutic potential of Toll-like receptor-9 activation. Nat. Rev. Drug Discov.5, 471–484 (2006).
   PubMed Web of Science ®Google Scholar
• Rankin R, Pontarollo R, Ioannou X et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev.11, 333–340 (2001).
   PubMedGoogle Scholar
• Romera SA, Hilgers LA, Puntel M et al. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle. Vaccine19, 132–141 (2000).
   PubMed Web of Science ®Google Scholar
• Kerkhofs P, Renjifo X, Toussaint JF, Letellier C, Vanopdenbosch E, Wellemans G. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine. Vet. Rec.152, 681–686 (2003).
   PubMed Web of Science ®Google Scholar
• Dale CJ, Thomson S, De Rose R et al. Prime–boost strategies in DNA vaccines. Methods Mol. Med.127, 171–197 (2006).
   PubMedGoogle Scholar
• Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveckzy CJ, Ramshaw IA. Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population. Int. Immunol.14, 31–37 (2002).
   PubMed Web of Science ®Google Scholar
• Ramshaw IA, Ramsay AJ. The prime–boost strategy: exciting prospects for improved vaccination. Immunol. Today21, 163–165 (2000).
   PubMedGoogle Scholar
• Galloway D, Liner A, Legutki J, Mateczun A, Barnewall R, Estep J. Genetic immunization against anthrax. Vaccine22, 1604–1608 (2004).
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang H, Fan X et al. DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine24, 4565–4568 (2006).
   PubMed Web of Science ®Google Scholar
• Liang R, van den Hurk JV, Babiuk LA, van Drunen Littel-van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from bovine viral diarrhea virus in cattle. J. Gen. Virol.87, 2971–2982 (2006).
   PubMed Web of Science ®Google Scholar
• Toussaint JF, Letellier C, Paquet D, Dispas M, Kerkhofs P. Prime–boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1. Vaccine23, 5073–5081 (2005).
   PubMed Web of Science ®Google Scholar
• Scarselli M, Giuliani MM, Adu-Bobie J, Pizza M, Rappuoli R. The impact of genomics on vaccine design. Trends Biotechnol.23, 84–91 (2005).
   PubMed Web of Science ®Google Scholar
• Braga-Neto UM, Marques ET Jr. From functional genomics to functional immunomics: new challenges, old problems, big rewards. PLoS Comput. Biol.2, e81 (2006).
   PubMed Web of Science ®Google Scholar